- Home
- USAS vs INMB Comparison
USAS vs INMB Comparison
Compare USAS & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- INMB
- Stock Information
- Founded
- USAS 1998
- INMB 2015
- Country
- USAS Canada
- INMB United States
- Employees
- USAS N/A
- INMB N/A
- Industry
- USAS Metal Mining
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- USAS Basic Materials
- INMB Health Care
- Exchange
- USAS Nasdaq
- INMB Nasdaq
- Market Cap
- USAS 122.4M
- INMB 109.9M
- IPO Year
- USAS N/A
- INMB 2019
- Fundamental
- Price
- USAS $0.38
- INMB $4.76
- Analyst Decision
- USAS Strong Buy
- INMB Strong Buy
- Analyst Count
- USAS 1
- INMB 2
- Target Price
- USAS $0.80
- INMB $21.00
- AVG Volume (30 Days)
- USAS 1.5M
- INMB 254.8K
- Earning Date
- USAS 11-07-2024
- INMB 10-31-2024
- Dividend Yield
- USAS N/A
- INMB N/A
- EPS Growth
- USAS N/A
- INMB N/A
- EPS
- USAS N/A
- INMB N/A
- Revenue
- USAS $97,123,000.00
- INMB $42,000.00
- Revenue This Year
- USAS $25.05
- INMB N/A
- Revenue Next Year
- USAS $35.97
- INMB N/A
- P/E Ratio
- USAS N/A
- INMB N/A
- Revenue Growth
- USAS 14.33
- INMB N/A
- 52 Week Low
- USAS $0.20
- INMB $4.45
- 52 Week High
- USAS $0.54
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- USAS 45.04
- INMB 36.74
- Support Level
- USAS $0.32
- INMB $4.45
- Resistance Level
- USAS $0.42
- INMB $6.26
- Average True Range (ATR)
- USAS 0.04
- INMB 0.31
- MACD
- USAS -0.01
- INMB -0.17
- Stochastic Oscillator
- USAS 37.38
- INMB 14.49
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.